Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.

Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis. Clin J Am Soc Nephrol. 2017 Aug 07; 12(8):1265-1273.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Aged, 80 and over
Biomarkers
Cause of Death
Diabetes Mellitus, Type 2
Diabetic Nephropathies
Disease-Free Survival
Female
Germany
Humans
Kaplan-Meier Estimate
Kidney Failure, Chronic
Male
Middle Aged
Proportional Hazards Models
Receptors, Urokinase Plasminogen Activator
Renal Dialysis
Risk Factors
Time Factors
Treatment Outcome
Young Adult